# US 2025/0205384 A1 · Hemostatic material

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0205384 A1
- Document ID: US20250205384A1
- Status: Published application
- Kind: A1
- Application number: 19/075,699
- Filed: 2025-03-10
- Published: 2025-06-26
- Earliest claimed: 2018-10-17
- Assignees: Toray Industries, Inc.
- Applicants: Toray Industries, Inc.
- Inventors: Shinji Takeoka; Keiko Nakahara; Mamoru Nishiura; Shinya Otsubo; Hajimu Kurumatani; Toru Arakane; Masanobu Takeda; Makoto Nakahara; Kumi Oyama
- Web page: https://patentgrep.com/patent/US20250205384A1

## CPC

- A61L 24/10: Polypeptides; Proteins {(A61L24/043 takes precedence)}
- A61K 9/1271: Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers (liposomes as conjugates {A61K47/6911})
- A61K 31/23: of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K 47/28: Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
- A61L 24/0015: {Medicaments; Biocides}
- A61L 24/0036: {Porous materials, e.g. foams or sponges}
- A61L 24/046: {obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds (A61L24/043 takes precedence)}
- A61L 24/08: Polysaccharides {(A61L24/043 takes precedence)}
- A61K 47/542: {Carboxylic acids, e.g. a fatty acid or an amino acid}
- A61K 47/6911: {the form being a liposome}
- A61L 2300/22: Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
- A61L 2400/04: Materials for stopping bleeding
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A hemostatic material includes a lipid that can accelerate adhesion or aggregation of platelets even if the lipid does not carry a protein or a peptide involved in adhesion or aggregation of platelets such as GPIb and H12 and, to achieve the object, provides a hemostatic material including a water-insoluble base and a lipid supported on a surface of the base, wherein the lipid includes one or two or more anionic lipids.

## Claims

### Claim 1

A hemostatic material comprising a water-insoluble porous base and a lipid supported on a surface of a pore of the porous base,
wherein the lipid comprises one or two or more anionic lipids in one or two or more forms selected from a lipid particle, an aggregate of a lipid particle and a lipid membrane,
wherein the one or two or more anionic lipids comprise one or two or more carboxylic acid-type lipids selected from carboxylic acid-type lipids represented by formulas (I) to (VI):
wherein, in formulas (I) to (VI),
M represents M0-NH—,
M0 represents a peptide residue or a salt thereof, wherein the peptide residue and the salt thereof can be negatively charged at physiological pH,
R represents a hydrocarbon group,
L represents —CO—O—, —O—CO—, —CO—NH—, —NH—CO—, —CO—S—, —S—CO— or —S—S—,
X represents a hydrocarbon group, a neutral amino acid residue or a polyalkylene glycol residue,
p represents an integer of 0 or more,
q represents an integer of 0 or more,
Y represents a branched chain composed of a branched chain body and one or more groups Y2 that are bonded to the branched chain body, or represents a straight chain composed of one group Y2, wherein the branched chain body is composed of one or more units Y1, wherein each unit Y1 is represented by formula (VII):
and wherein each group Y2 is represented by formula (VIII):
(*b4)-[L-X]p-L-R (VIII)
wherein, in formulas (VII) and (VIII),
R, L, X, p and q are the same as defined above,
(*b1), (*b2) and (*b3) represent a bond of each unit Y1,
(*b4) represents a bond of each group Y2,
the bond (*b1) of each unit Y1 is bonded to (CH2)q in formula (III), (IV) or (VI), or is bonded to a bond (*b2) or (*b3) of another unit Y1 constituting the branched chain body, and
the bond (*b4) of each group Y2 is bonded to (CH2)q in formula (III), (IV) or (VI), or is bonded to a bond (*b2) or (*b3) of any unit Y1 constituting the branched chain body,
Z represents a branched chain composed of a branched chain body and one or more groups Z2 that are bonded to the branched chain body, or represents a straight chain composed of one group Z2, wherein the branched chain body is composed of one or more units Z1, wherein each unit Z1 is represented by formula (IX):
and wherein each group Z2 is selected from groups represented by formulas (X) and (XI):
wherein, in formulas (IX), (X) and (XI),
M, L, X, p and q are the same as defined above,
(*c1), (*c2) and (*c3) represent a bond of each unit Z1,
(*c4) and (*c5) represent a bond of each group Z2,
the bond (*c1) of each unit Z1 is bonded to (CH2)q in formula (V) or (VI), or is bonded to a bond (*c2) or (*c3) of another unit Z1 constituting the branched chain body, and
the bond (*c4) or (*c5) of each group Z2 is bonded to (CH2)q in formula (V) or (VI), or is bonded to a bond (*c2) or (*c3) of any unit Z1 constituting the branched chain body.

### Claim 2 (depends on 1)

The hemostatic material according to claim 1, wherein the lipid accounts for at least a part of the pore of the porous base.

### Claim 3 (depends on 1)

The hemostatic material according to claim 1, wherein the porous base is a fiber base.

### Claim 4 (depends on 1)

The hemostatic material according to claim 1, wherein the peptide residue represented by M0 is a peptide residue comprising one or two or more acidic amino acid residues.

### Claim 5 (depends on 4)

The hemostatic material according to claim 4, wherein the peptide residue represented by M0 is a peptide residue comprising two or more acidic amino acid residues selected from an aspartic acid residue and a glutamic acid residue.

### Claim 6 (depends on 5)

The hemostatic material according to claim 5, wherein the peptide residue represented by M0 is a peptide residue represented by formula (XII):
wherein m is the same or different and represents 1 or 2.

### Claim 7 (depends on 1)

The hemostatic material according to claim 1, wherein Y is selected from straight and branched chains represented by formulas (XIII), (XIV), (XV) and (XVI):
wherein, in formulas (XIII) to (XVI),
Y1 represents one unit Y1,
Y2 represents one group Y2, and
(*b) represents a bond of the unit Y1 bonded to (CH2)q in formula (III), (IV) or (VI).

### Claim 8 (depends on 1)

The hemostatic material according to claim 1, wherein Z is selected from straight and branched chains represented by formulas (XVII), (XVIII), (XIX) and (XX):
wherein, in formulas (XVII) to (XX),
Z1 represents one unit Z1,
Z2 represents one group Z2, and
(*c) represents a bond of the unit Z1 bonded to (CH2)q in formula (V) or (VI).

### Claim 9 (depends on 1)

The hemostatic material according to claim 1, wherein the one or two or more anionic lipids further comprise one or two or more lipids selected from a phospholipid and a sterol.

### Claim 10 (depends on 1)

The hemostatic material according to claim 1, wherein the lipid is supported on a surface of a pore of the porous base in a lipid membrane.
